While nothing much came out of bigwigs apart from a few, shares of clinical-stage biotechs like Disc Medicine, Inc. IRON and Verve Therapeutics VERV plunged on disappointing updates. Updates From ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback